Article
PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter-Individual Variability.
CPT: pharmacometrics & systems pharmacology - 1 Feb 2021
Takita Hiroyuki, Barnett Shelby, Zhang Yueping, Ménochet Karelle, Shen Hong, Ogungbenro Kayode, Galetin Aleksandra
Abstract excerpt
Coproporphyrin I (CPI) is an endogenous biomarker of OATP1B activity and associated drug-drug interactions. In this study, a minimal physiologically-based pharmacokinetic model was developed to investigate the impact of OATP1B1 genotype (c.521T>C), ethnicity, and sex on CPI pharmacokinetics and interindividual variability in its baseline. The model implemented mechanistic descriptions of CPI hepatic transport...
Topics
Join the communities discussing this publication.
